These pharmacological agents are highly significant to designing precision treatments as tumors frequently display dependency upon BCL-2 or MCL-1, and chemo-resistant tumors often shift reliance between anti-apoptotic BCL-2 proteins.
← all excerpts
Putting the pieces together: How is the mitochondrial pathway of apoptosis regulated in cancer and chemotherapy?
1
—
—